当前位置: X-MOL 学术Endocr. Pathol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Exploring the Prognostic Role of Ki67 Proliferative Index in Merkel Cell Carcinoma of the Skin: Clinico-Pathologic Analysis of 84 Cases and Review of the Literature.
Endocrine Pathology ( IF 4.4 ) Pub Date : 2020-07-22 , DOI: 10.1007/s12022-020-09640-3
Stefano La Rosa 1, 2 , Matteo Bonzini 3 , Amedeo Sciarra 4 , Sofia Asioli 5 , Roberta Maragliano 6 , Martina Arrigo 7 , Maria Pia Foschini 5 , Alberto Righi 8 , Francesca Maletta 9 , Alberico Motolese 7 , Mauro Papotti 9 , Fausto Sessa 6 , Silvia Uccella 6
Affiliation  

The exact prediction of outcome of patients with Merkel cell carcinoma (MCC) of the skin is difficult to determine, although several attempts have been made to identify clinico-pathologic prognostic factors. The Ki67 proliferative index is a well-known marker routinely used to define the prognosis of patients with neuroendocrine neoplasms. However, its prognostic value has been poorly investigated in MCC, and available published results are often contradictory mainly because restricted to small series in the absence of standardized methods for Ki67 evaluation. For this reason, we explored the potential prognostic role of Ki67 proliferative index in a large series of MCCs using the WHO standardized method of counting positive cells in at least 500 tumor cells in hot spot areas on camera-captured printed images. In addition, since MCC may be considered as the cutaneous counterpart of digestive neuroendocrine carcinomas (NECs), we decided to stratify MCCs using the available and efficient Ki67 threshold of 55%, which was found prognostic in digestive NECs. This choice was also supported by the Youden index analysis. In addition, we analyzed the prognostic value of other clinico-pathologic parameters using both univariate and multivariate analysis. Ki67 index appeared significantly associated with prognosis at univariate analysis together with stage IV, lack of MCPyV, and p63 expression, but not at the multivariate analysis, where survival resulted independently influenced by p63 expression and tumor stage, only.



中文翻译:

探索 Ki67 增殖指数在皮肤默克尔细胞癌中的预后作用:84 例临床病理分析及文献复习。

皮肤默克尔细胞癌 (MCC) 患者预后的准确预测很难确定,尽管已经进行了多次尝试来确定临床病理预后因素。Ki67 增殖指数是众所周知的标志物,通常用于定义神经内分泌肿瘤患者的预后。然而,它的预后价值在 MCC 中的研究很少,并且可用的已发表结果通常相互矛盾,主要是因为在缺乏 Ki67 评估的标准化方法的情况下仅限于小系列。出于这个原因,我们使用 WHO 标准化方法在相机捕获的打印图像的热点区域中对至少 500 个肿瘤细胞中的阳性细胞进行计数,探讨了 Ki67 增殖指数在大量 MCC 中的潜在预后作用。此外,由于 MCC 可能被认为是消化性神经内分泌癌 (NEC) 的皮肤对应物,因此我们决定使用 55% 的可用且有效的 Ki67 阈值对 MCC 进行分层,该阈值在消化性 NEC 中被发现具有预后意义。Youden 指数分析也支持这一选择。此外,我们使用单变量和多变量分析分析了其他临床病理参数的预后价值。Ki67 指数与 IV 期、缺乏 MCPyV 和 p63 表达的单变量分析中的预后显着相关,但与多变量分析无关,其中生存率仅受 p63 表达和肿瘤分期的独立影响。我们决定使用 55% 的可用且有效的 Ki67 阈值对 MCC 进行分层,该阈值在消化 NEC 中具有预后作用。Youden 指数分析也支持这一选择。此外,我们使用单变量和多变量分析分析了其他临床病理参数的预后价值。Ki67 指数与 IV 期、缺乏 MCPyV 和 p63 表达的单变量分析中的预后显着相关,但与多变量分析无关,其中生存率仅受 p63 表达和肿瘤分期的独立影响。我们决定使用 55% 的可用且有效的 Ki67 阈值对 MCC 进行分层,该阈值在消化 NEC 中被发现具有预后意义。Youden 指数分析也支持这一选择。此外,我们使用单变量和多变量分析分析了其他临床病理参数的预后价值。Ki67 指数与 IV 期、缺乏 MCPyV 和 p63 表达的单变量分析中的预后显着相关,但与多变量分析无关,其中生存率仅受 p63 表达和肿瘤分期的独立影响。

更新日期:2020-07-22
down
wechat
bug